nodes	percent_of_prediction	percent_of_DWPC	metapath
Mifepristone—PGR—uterine cancer	0.339	1	CbGaD
Mifepristone—PGR—Medroxyprogesterone Acetate—uterine cancer	0.0916	0.172	CbGbCtD
Mifepristone—AR—Medroxyprogesterone Acetate—uterine cancer	0.0735	0.138	CbGbCtD
Mifepristone—PGR—Progesterone—uterine cancer	0.0607	0.114	CbGbCtD
Mifepristone—AR—Progesterone—uterine cancer	0.0487	0.0915	CbGbCtD
Mifepristone—NR3C1—Medroxyprogesterone Acetate—uterine cancer	0.0468	0.0878	CbGbCtD
Mifepristone—NR3C1—Progesterone—uterine cancer	0.031	0.0582	CbGbCtD
Mifepristone—ABCC1—Progesterone—uterine cancer	0.0299	0.0562	CbGbCtD
Mifepristone—ABCC1—Dactinomycin—uterine cancer	0.0237	0.0445	CbGbCtD
Mifepristone—ABCC1—Epirubicin—uterine cancer	0.0172	0.0323	CbGbCtD
Mifepristone—CYP3A7-CYP3A51P—Progesterone—uterine cancer	0.0148	0.0278	CbGbCtD
Mifepristone—CYP3A7—Progesterone—uterine cancer	0.0148	0.0278	CbGbCtD
Mifepristone—ABCC1—Etoposide—uterine cancer	0.0134	0.0251	CbGbCtD
Mifepristone—CYP3A5—Progesterone—uterine cancer	0.0111	0.0208	CbGbCtD
Mifepristone—ABCC1—Doxorubicin—uterine cancer	0.00913	0.0171	CbGbCtD
Mifepristone—PGR—corpus luteum—uterine cancer	0.00736	0.184	CbGeAlD
Mifepristone—ABCB1—Progesterone—uterine cancer	0.00721	0.0136	CbGbCtD
Mifepristone—CYP2D6—Progesterone—uterine cancer	0.0068	0.0128	CbGbCtD
Mifepristone—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.00653	0.0123	CbGbCtD
Mifepristone—ABCB1—Dactinomycin—uterine cancer	0.00572	0.0107	CbGbCtD
Mifepristone—CYP3A5—Etoposide—uterine cancer	0.00496	0.00932	CbGbCtD
Mifepristone—CYP3A4—Progesterone—uterine cancer	0.00432	0.00812	CbGbCtD
Mifepristone—ABCB1—Etoposide—uterine cancer	0.00323	0.00606	CbGbCtD
Mifepristone—AR—semen—uterine cancer	0.00275	0.0686	CbGeAlD
Mifepristone—PGR—oviduct—uterine cancer	0.00253	0.0631	CbGeAlD
Mifepristone—ABCB1—Doxorubicin—uterine cancer	0.0022	0.00414	CbGbCtD
Mifepristone—CYP2D6—Doxorubicin—uterine cancer	0.00207	0.0039	CbGbCtD
Mifepristone—AR—oviduct—uterine cancer	0.00201	0.0503	CbGeAlD
Mifepristone—CYP3A4—Etoposide—uterine cancer	0.00193	0.00363	CbGbCtD
Mifepristone—PGR—artery—uterine cancer	0.00167	0.0418	CbGeAlD
Mifepristone—CYP3A4—Doxorubicin—uterine cancer	0.00132	0.00248	CbGbCtD
Mifepristone—PGR—myometrium—uterine cancer	0.000809	0.0202	CbGeAlD
Mifepristone—AR—myometrium—uterine cancer	0.000644	0.0161	CbGeAlD
Mifepristone—PGR—epithelium—uterine cancer	0.000635	0.0159	CbGeAlD
Mifepristone—PGR—uterine cervix—uterine cancer	0.000629	0.0157	CbGeAlD
Mifepristone—ABCC1—myometrium—uterine cancer	0.000612	0.0153	CbGeAlD
Mifepristone—PGR—smooth muscle tissue—uterine cancer	0.000612	0.0153	CbGeAlD
Mifepristone—PGR—decidua—uterine cancer	0.0006	0.015	CbGeAlD
Mifepristone—PGR—endometrium—uterine cancer	0.000569	0.0142	CbGeAlD
Mifepristone—PGR—uterus—uterine cancer	0.000525	0.0131	CbGeAlD
Mifepristone—AR—epithelium—uterine cancer	0.000506	0.0126	CbGeAlD
Mifepristone—AR—uterine cervix—uterine cancer	0.000501	0.0125	CbGeAlD
Mifepristone—AR—smooth muscle tissue—uterine cancer	0.000487	0.0122	CbGeAlD
Mifepristone—AR—decidua—uterine cancer	0.000478	0.0119	CbGeAlD
Mifepristone—ABCC1—uterine cervix—uterine cancer	0.000476	0.0119	CbGeAlD
Mifepristone—PGR—female reproductive system—uterine cancer	0.000472	0.0118	CbGeAlD
Mifepristone—AR—renal system—uterine cancer	0.000469	0.0117	CbGeAlD
Mifepristone—NR3C1—myometrium—uterine cancer	0.000467	0.0117	CbGeAlD
Mifepristone—ABCC1—decidua—uterine cancer	0.000454	0.0113	CbGeAlD
Mifepristone—AR—endometrium—uterine cancer	0.000454	0.0113	CbGeAlD
Mifepristone—AR—mammalian vulva—uterine cancer	0.000439	0.011	CbGeAlD
Mifepristone—ABCC1—endometrium—uterine cancer	0.000431	0.0108	CbGeAlD
Mifepristone—PGR—female gonad—uterine cancer	0.000429	0.0107	CbGeAlD
Mifepristone—PGR—vagina—uterine cancer	0.000426	0.0107	CbGeAlD
Mifepristone—AR—uterus—uterine cancer	0.000418	0.0104	CbGeAlD
Mifepristone—ABCC1—mammalian vulva—uterine cancer	0.000417	0.0104	CbGeAlD
Mifepristone—ABCC1—uterus—uterine cancer	0.000397	0.00991	CbGeAlD
Mifepristone—AR—female reproductive system—uterine cancer	0.000376	0.00938	CbGeAlD
Mifepristone—NR3C1—epithelium—uterine cancer	0.000366	0.00915	CbGeAlD
Mifepristone—CYP3A5—uterine cervix—uterine cancer	0.000366	0.00914	CbGeAlD
Mifepristone—NR3C1—uterine cervix—uterine cancer	0.000363	0.00907	CbGeAlD
Mifepristone—NR3C1—smooth muscle tissue—uterine cancer	0.000353	0.00881	CbGeAlD
Mifepristone—NR3C1—decidua—uterine cancer	0.000346	0.00864	CbGeAlD
Mifepristone—CYP3A5—renal system—uterine cancer	0.000342	0.00855	CbGeAlD
Mifepristone—AR—female gonad—uterine cancer	0.000342	0.00854	CbGeAlD
Mifepristone—AR—vagina—uterine cancer	0.00034	0.00849	CbGeAlD
Mifepristone—NR3C1—renal system—uterine cancer	0.00034	0.00849	CbGeAlD
Mifepristone—NR3C1—endometrium—uterine cancer	0.000328	0.0082	CbGeAlD
Mifepristone—ABCC1—female gonad—uterine cancer	0.000325	0.00811	CbGeAlD
Mifepristone—ABCC1—vagina—uterine cancer	0.000323	0.00806	CbGeAlD
Mifepristone—NR3C1—mammalian vulva—uterine cancer	0.000318	0.00794	CbGeAlD
Mifepristone—NR3C1—uterus—uterine cancer	0.000303	0.00756	CbGeAlD
Mifepristone—PGR—lymph node—uterine cancer	0.000276	0.00689	CbGeAlD
Mifepristone—NR3C1—female reproductive system—uterine cancer	0.000272	0.0068	CbGeAlD
Mifepristone—CYP3A4—renal system—uterine cancer	0.000257	0.00642	CbGeAlD
Mifepristone—CYP2D6—renal system—uterine cancer	0.000253	0.00631	CbGeAlD
Mifepristone—ABCB1—myometrium—uterine cancer	0.00025	0.00624	CbGeAlD
Mifepristone—CYP3A5—female gonad—uterine cancer	0.00025	0.00623	CbGeAlD
Mifepristone—CYP3A5—vagina—uterine cancer	0.000248	0.00619	CbGeAlD
Mifepristone—NR3C1—female gonad—uterine cancer	0.000248	0.00618	CbGeAlD
Mifepristone—NR3C1—vagina—uterine cancer	0.000246	0.00615	CbGeAlD
Mifepristone—Arthralgia—Medroxyprogesterone Acetate—uterine cancer	0.000238	0.00358	CcSEcCtD
Mifepristone—Myalgia—Medroxyprogesterone Acetate—uterine cancer	0.000238	0.00358	CcSEcCtD
Mifepristone—Anxiety—Medroxyprogesterone Acetate—uterine cancer	0.000237	0.00357	CcSEcCtD
Mifepristone—Unspecified disorder of skin and subcutaneous tissue—Medroxyprogesterone Acetate—uterine cancer	0.000236	0.00355	CcSEcCtD
Mifepristone—Toxic epidermal necrolysis—Etoposide—uterine cancer	0.000236	0.00355	CcSEcCtD
Mifepristone—Cramp muscle—Etoposide—uterine cancer	0.000236	0.00355	CcSEcCtD
Mifepristone—Hypotension—Progesterone—uterine cancer	0.000235	0.00354	CcSEcCtD
Mifepristone—Discomfort—Medroxyprogesterone Acetate—uterine cancer	0.000235	0.00354	CcSEcCtD
Mifepristone—Dry mouth—Medroxyprogesterone Acetate—uterine cancer	0.000233	0.0035	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Progesterone—uterine cancer	0.000229	0.00345	CcSEcCtD
Mifepristone—Oedema—Medroxyprogesterone Acetate—uterine cancer	0.000228	0.00343	CcSEcCtD
Mifepristone—Insomnia—Progesterone—uterine cancer	0.000228	0.00343	CcSEcCtD
Mifepristone—Infection—Medroxyprogesterone Acetate—uterine cancer	0.000227	0.00341	CcSEcCtD
Mifepristone—Chills—Dactinomycin—uterine cancer	0.000225	0.00338	CcSEcCtD
Mifepristone—Dyspnoea—Progesterone—uterine cancer	0.000224	0.00338	CcSEcCtD
Mifepristone—Somnolence—Progesterone—uterine cancer	0.000224	0.00337	CcSEcCtD
Mifepristone—Nervous system disorder—Medroxyprogesterone Acetate—uterine cancer	0.000224	0.00337	CcSEcCtD
Mifepristone—Skin disorder—Medroxyprogesterone Acetate—uterine cancer	0.000221	0.00333	CcSEcCtD
Mifepristone—AR—lymph node—uterine cancer	0.00022	0.00549	CbGeAlD
Mifepristone—Decreased appetite—Progesterone—uterine cancer	0.000219	0.00329	CcSEcCtD
Mifepristone—Anorexia—Medroxyprogesterone Acetate—uterine cancer	0.000217	0.00327	CcSEcCtD
Mifepristone—Gastrointestinal disorder—Progesterone—uterine cancer	0.000217	0.00327	CcSEcCtD
Mifepristone—Fatigue—Progesterone—uterine cancer	0.000217	0.00326	CcSEcCtD
Mifepristone—Pain—Progesterone—uterine cancer	0.000215	0.00324	CcSEcCtD
Mifepristone—Constipation—Progesterone—uterine cancer	0.000215	0.00324	CcSEcCtD
Mifepristone—Hypotension—Medroxyprogesterone Acetate—uterine cancer	0.000213	0.00321	CcSEcCtD
Mifepristone—ABCC1—lymph node—uterine cancer	0.000209	0.00521	CbGeAlD
Mifepristone—Musculoskeletal discomfort—Medroxyprogesterone Acetate—uterine cancer	0.000208	0.00313	CcSEcCtD
Mifepristone—Feeling abnormal—Progesterone—uterine cancer	0.000207	0.00312	CcSEcCtD
Mifepristone—Insomnia—Medroxyprogesterone Acetate—uterine cancer	0.000206	0.0031	CcSEcCtD
Mifepristone—CYP3A4—female reproductive system—uterine cancer	0.000206	0.00514	CbGeAlD
Mifepristone—Gastrointestinal pain—Progesterone—uterine cancer	0.000206	0.0031	CcSEcCtD
Mifepristone—Dyspnoea—Medroxyprogesterone Acetate—uterine cancer	0.000203	0.00306	CcSEcCtD
Mifepristone—Somnolence—Medroxyprogesterone Acetate—uterine cancer	0.000203	0.00305	CcSEcCtD
Mifepristone—CYP2D6—female reproductive system—uterine cancer	0.000203	0.00506	CbGeAlD
Mifepristone—Ill-defined disorder—Dactinomycin—uterine cancer	0.000202	0.00304	CcSEcCtD
Mifepristone—Infestation—Etoposide—uterine cancer	0.000202	0.00304	CcSEcCtD
Mifepristone—Infestation NOS—Etoposide—uterine cancer	0.000202	0.00304	CcSEcCtD
Mifepristone—Urticaria—Progesterone—uterine cancer	0.0002	0.00301	CcSEcCtD
Mifepristone—Body temperature increased—Progesterone—uterine cancer	0.000199	0.00299	CcSEcCtD
Mifepristone—Abdominal pain—Progesterone—uterine cancer	0.000199	0.00299	CcSEcCtD
Mifepristone—Decreased appetite—Medroxyprogesterone Acetate—uterine cancer	0.000198	0.00298	CcSEcCtD
Mifepristone—Gastrointestinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.000197	0.00296	CcSEcCtD
Mifepristone—Fatigue—Medroxyprogesterone Acetate—uterine cancer	0.000197	0.00296	CcSEcCtD
Mifepristone—Malaise—Dactinomycin—uterine cancer	0.000197	0.00296	CcSEcCtD
Mifepristone—ABCB1—epithelium—uterine cancer	0.000196	0.0049	CbGeAlD
Mifepristone—Constipation—Medroxyprogesterone Acetate—uterine cancer	0.000195	0.00293	CcSEcCtD
Mifepristone—ABCB1—uterine cervix—uterine cancer	0.000194	0.00486	CbGeAlD
Mifepristone—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.000188	0.00283	CcSEcCtD
Mifepristone—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.000186	0.00281	CcSEcCtD
Mifepristone—Myalgia—Dactinomycin—uterine cancer	0.000186	0.00279	CcSEcCtD
Mifepristone—Hypersensitivity—Progesterone—uterine cancer	0.000185	0.00279	CcSEcCtD
Mifepristone—ABCB1—decidua—uterine cancer	0.000185	0.00463	CbGeAlD
Mifepristone—CYP2D6—female gonad—uterine cancer	0.000184	0.0046	CbGeAlD
Mifepristone—Rash maculo-papular—Epirubicin—uterine cancer	0.000184	0.00277	CcSEcCtD
Mifepristone—Discomfort—Dactinomycin—uterine cancer	0.000183	0.00276	CcSEcCtD
Mifepristone—ABCB1—renal system—uterine cancer	0.000182	0.00454	CbGeAlD
Mifepristone—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.000181	0.00273	CcSEcCtD
Mifepristone—Asthenia—Progesterone—uterine cancer	0.000181	0.00272	CcSEcCtD
Mifepristone—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.00018	0.00271	CcSEcCtD
Mifepristone—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.00018	0.00271	CcSEcCtD
Mifepristone—Pruritus—Progesterone—uterine cancer	0.000178	0.00268	CcSEcCtD
Mifepristone—Oedema—Dactinomycin—uterine cancer	0.000178	0.00268	CcSEcCtD
Mifepristone—Infection—Dactinomycin—uterine cancer	0.000177	0.00266	CcSEcCtD
Mifepristone—ABCB1—endometrium—uterine cancer	0.000176	0.00439	CbGeAlD
Mifepristone—Diarrhoea—Progesterone—uterine cancer	0.000172	0.00259	CcSEcCtD
Mifepristone—ABCB1—mammalian vulva—uterine cancer	0.00017	0.00425	CbGeAlD
Mifepristone—Rash maculo-papular—Doxorubicin—uterine cancer	0.00017	0.00256	CcSEcCtD
Mifepristone—Anorexia—Dactinomycin—uterine cancer	0.00017	0.00255	CcSEcCtD
Mifepristone—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.000168	0.00253	CcSEcCtD
Mifepristone—Dizziness—Progesterone—uterine cancer	0.000166	0.0025	CcSEcCtD
Mifepristone—Angiopathy—Etoposide—uterine cancer	0.000164	0.00247	CcSEcCtD
Mifepristone—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.000164	0.00246	CcSEcCtD
Mifepristone—Mediastinal disorder—Etoposide—uterine cancer	0.000163	0.00246	CcSEcCtD
Mifepristone—Chills—Etoposide—uterine cancer	0.000163	0.00245	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.000162	0.00244	CcSEcCtD
Mifepristone—ABCB1—uterus—uterine cancer	0.000162	0.00405	CbGeAlD
Mifepristone—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.000161	0.00243	CcSEcCtD
Mifepristone—Vomiting—Progesterone—uterine cancer	0.00016	0.00241	CcSEcCtD
Mifepristone—NR3C1—lymph node—uterine cancer	0.000159	0.00398	CbGeAlD
Mifepristone—Rash—Progesterone—uterine cancer	0.000159	0.00239	CcSEcCtD
Mifepristone—Dermatitis—Progesterone—uterine cancer	0.000159	0.00239	CcSEcCtD
Mifepristone—Headache—Progesterone—uterine cancer	0.000158	0.00237	CcSEcCtD
Mifepristone—Hot flush—Epirubicin—uterine cancer	0.000157	0.00236	CcSEcCtD
Mifepristone—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000156	0.00235	CcSEcCtD
Mifepristone—Dermatitis exfoliative—Epirubicin—uterine cancer	0.000156	0.00234	CcSEcCtD
Mifepristone—Menopausal symptoms—Epirubicin—uterine cancer	0.000156	0.00234	CcSEcCtD
Mifepristone—Decreased appetite—Dactinomycin—uterine cancer	0.000155	0.00233	CcSEcCtD
Mifepristone—Fatigue—Dactinomycin—uterine cancer	0.000153	0.00231	CcSEcCtD
Mifepristone—Back pain—Etoposide—uterine cancer	0.000153	0.0023	CcSEcCtD
Mifepristone—Pain—Dactinomycin—uterine cancer	0.000152	0.00229	CcSEcCtD
Mifepristone—Muscle spasms—Etoposide—uterine cancer	0.000152	0.00228	CcSEcCtD
Mifepristone—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000151	0.00227	CcSEcCtD
Mifepristone—Hypoglycaemia—Epirubicin—uterine cancer	0.00015	0.00226	CcSEcCtD
Mifepristone—Nausea—Progesterone—uterine cancer	0.000149	0.00225	CcSEcCtD
Mifepristone—Pain in extremity—Epirubicin—uterine cancer	0.000147	0.00221	CcSEcCtD
Mifepristone—Feeling abnormal—Dactinomycin—uterine cancer	0.000147	0.00221	CcSEcCtD
Mifepristone—Ill-defined disorder—Etoposide—uterine cancer	0.000146	0.0022	CcSEcCtD
Mifepristone—ABCB1—female reproductive system—uterine cancer	0.000146	0.00364	CbGeAlD
Mifepristone—Gastrointestinal pain—Dactinomycin—uterine cancer	0.000145	0.00219	CcSEcCtD
Mifepristone—Hot flush—Doxorubicin—uterine cancer	0.000145	0.00219	CcSEcCtD
Mifepristone—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000145	0.00218	CcSEcCtD
Mifepristone—Dermatitis exfoliative—Doxorubicin—uterine cancer	0.000144	0.00217	CcSEcCtD
Mifepristone—Menopausal symptoms—Doxorubicin—uterine cancer	0.000144	0.00217	CcSEcCtD
Mifepristone—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000144	0.00216	CcSEcCtD
Mifepristone—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000144	0.00216	CcSEcCtD
Mifepristone—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000143	0.00215	CcSEcCtD
Mifepristone—Malaise—Etoposide—uterine cancer	0.000142	0.00214	CcSEcCtD
Mifepristone—Abdominal pain—Dactinomycin—uterine cancer	0.000141	0.00212	CcSEcCtD
Mifepristone—Body temperature increased—Dactinomycin—uterine cancer	0.000141	0.00212	CcSEcCtD
Mifepristone—Hypoglycaemia—Doxorubicin—uterine cancer	0.000139	0.00209	CcSEcCtD
Mifepristone—Hypertension—Etoposide—uterine cancer	0.000136	0.00205	CcSEcCtD
Mifepristone—Pain in extremity—Doxorubicin—uterine cancer	0.000136	0.00204	CcSEcCtD
Mifepristone—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000135	0.00204	CcSEcCtD
Mifepristone—Hypokalaemia—Epirubicin—uterine cancer	0.000134	0.00201	CcSEcCtD
Mifepristone—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.000133	0.00201	CcSEcCtD
Mifepristone—Discomfort—Etoposide—uterine cancer	0.000133	0.002	CcSEcCtD
Mifepristone—Breast disorder—Epirubicin—uterine cancer	0.000133	0.002	CcSEcCtD
Mifepristone—ABCB1—female gonad—uterine cancer	0.000133	0.00331	CbGeAlD
Mifepristone—Toxic epidermal necrolysis—Epirubicin—uterine cancer	0.000132	0.00199	CcSEcCtD
Mifepristone—ABCB1—vagina—uterine cancer	0.000132	0.00329	CbGeAlD
Mifepristone—Nasopharyngitis—Epirubicin—uterine cancer	0.000131	0.00198	CcSEcCtD
Mifepristone—Hypersensitivity—Dactinomycin—uterine cancer	0.000131	0.00197	CcSEcCtD
Mifepristone—Muscular weakness—Epirubicin—uterine cancer	0.000129	0.00195	CcSEcCtD
Mifepristone—Infection—Etoposide—uterine cancer	0.000128	0.00192	CcSEcCtD
Mifepristone—Asthenia—Dactinomycin—uterine cancer	0.000128	0.00192	CcSEcCtD
Mifepristone—Skin disorder—Etoposide—uterine cancer	0.000125	0.00188	CcSEcCtD
Mifepristone—Hypokalaemia—Doxorubicin—uterine cancer	0.000124	0.00186	CcSEcCtD
Mifepristone—Breast disorder—Doxorubicin—uterine cancer	0.000123	0.00185	CcSEcCtD
Mifepristone—Anorexia—Etoposide—uterine cancer	0.000123	0.00185	CcSEcCtD
Mifepristone—Toxic epidermal necrolysis—Doxorubicin—uterine cancer	0.000122	0.00184	CcSEcCtD
Mifepristone—Diarrhoea—Dactinomycin—uterine cancer	0.000122	0.00183	CcSEcCtD
Mifepristone—Nasopharyngitis—Doxorubicin—uterine cancer	0.000121	0.00183	CcSEcCtD
Mifepristone—Hypotension—Etoposide—uterine cancer	0.00012	0.00181	CcSEcCtD
Mifepristone—Muscular weakness—Doxorubicin—uterine cancer	0.00012	0.0018	CcSEcCtD
Mifepristone—Dyspnoea—Etoposide—uterine cancer	0.000115	0.00173	CcSEcCtD
Mifepristone—Somnolence—Etoposide—uterine cancer	0.000114	0.00172	CcSEcCtD
Mifepristone—Infestation NOS—Epirubicin—uterine cancer	0.000113	0.0017	CcSEcCtD
Mifepristone—Infestation—Epirubicin—uterine cancer	0.000113	0.0017	CcSEcCtD
Mifepristone—Vomiting—Dactinomycin—uterine cancer	0.000113	0.0017	CcSEcCtD
Mifepristone—Rash—Dactinomycin—uterine cancer	0.000112	0.00169	CcSEcCtD
Mifepristone—Decreased appetite—Etoposide—uterine cancer	0.000112	0.00168	CcSEcCtD
Mifepristone—Gastrointestinal disorder—Etoposide—uterine cancer	0.000111	0.00167	CcSEcCtD
Mifepristone—Fatigue—Etoposide—uterine cancer	0.000111	0.00167	CcSEcCtD
Mifepristone—Pain—Etoposide—uterine cancer	0.00011	0.00166	CcSEcCtD
Mifepristone—Constipation—Etoposide—uterine cancer	0.00011	0.00166	CcSEcCtD
Mifepristone—Sinusitis—Epirubicin—uterine cancer	0.000106	0.0016	CcSEcCtD
Mifepristone—Feeling abnormal—Etoposide—uterine cancer	0.000106	0.0016	CcSEcCtD
Mifepristone—Nausea—Dactinomycin—uterine cancer	0.000106	0.00159	CcSEcCtD
Mifepristone—Gastrointestinal pain—Etoposide—uterine cancer	0.000105	0.00158	CcSEcCtD
Mifepristone—Infestation NOS—Doxorubicin—uterine cancer	0.000105	0.00158	CcSEcCtD
Mifepristone—Infestation—Doxorubicin—uterine cancer	0.000105	0.00158	CcSEcCtD
Mifepristone—Urticaria—Etoposide—uterine cancer	0.000102	0.00154	CcSEcCtD
Mifepristone—Haemoglobin—Epirubicin—uterine cancer	0.000102	0.00154	CcSEcCtD
Mifepristone—Abdominal pain—Etoposide—uterine cancer	0.000102	0.00153	CcSEcCtD
Mifepristone—Body temperature increased—Etoposide—uterine cancer	0.000102	0.00153	CcSEcCtD
Mifepristone—Haemorrhage—Epirubicin—uterine cancer	0.000102	0.00153	CcSEcCtD
Mifepristone—Oedema peripheral—Epirubicin—uterine cancer	0.0001	0.00151	CcSEcCtD
Mifepristone—Connective tissue disorder—Epirubicin—uterine cancer	9.98e-05	0.0015	CcSEcCtD
Mifepristone—Sinusitis—Doxorubicin—uterine cancer	9.82e-05	0.00148	CcSEcCtD
Mifepristone—Hypersensitivity—Etoposide—uterine cancer	9.48e-05	0.00143	CcSEcCtD
Mifepristone—Haemoglobin—Doxorubicin—uterine cancer	9.45e-05	0.00142	CcSEcCtD
Mifepristone—Haemorrhage—Doxorubicin—uterine cancer	9.4e-05	0.00141	CcSEcCtD
Mifepristone—Oedema peripheral—Doxorubicin—uterine cancer	9.26e-05	0.00139	CcSEcCtD
Mifepristone—Asthenia—Etoposide—uterine cancer	9.24e-05	0.00139	CcSEcCtD
Mifepristone—Connective tissue disorder—Doxorubicin—uterine cancer	9.24e-05	0.00139	CcSEcCtD
Mifepristone—Angiopathy—Epirubicin—uterine cancer	9.22e-05	0.00139	CcSEcCtD
Mifepristone—Mediastinal disorder—Epirubicin—uterine cancer	9.15e-05	0.00138	CcSEcCtD
Mifepristone—Chills—Epirubicin—uterine cancer	9.11e-05	0.00137	CcSEcCtD
Mifepristone—Pruritus—Etoposide—uterine cancer	9.11e-05	0.00137	CcSEcCtD
Mifepristone—Mental disorder—Epirubicin—uterine cancer	8.9e-05	0.00134	CcSEcCtD
Mifepristone—Malnutrition—Epirubicin—uterine cancer	8.84e-05	0.00133	CcSEcCtD
Mifepristone—Diarrhoea—Etoposide—uterine cancer	8.81e-05	0.00133	CcSEcCtD
Mifepristone—Back pain—Epirubicin—uterine cancer	8.55e-05	0.00129	CcSEcCtD
Mifepristone—Angiopathy—Doxorubicin—uterine cancer	8.53e-05	0.00128	CcSEcCtD
Mifepristone—ABCB1—lymph node—uterine cancer	8.52e-05	0.00213	CbGeAlD
Mifepristone—Dizziness—Etoposide—uterine cancer	8.51e-05	0.00128	CcSEcCtD
Mifepristone—Muscle spasms—Epirubicin—uterine cancer	8.5e-05	0.00128	CcSEcCtD
Mifepristone—Mediastinal disorder—Doxorubicin—uterine cancer	8.47e-05	0.00127	CcSEcCtD
Mifepristone—Chills—Doxorubicin—uterine cancer	8.43e-05	0.00127	CcSEcCtD
Mifepristone—Mental disorder—Doxorubicin—uterine cancer	8.23e-05	0.00124	CcSEcCtD
Mifepristone—Ill-defined disorder—Epirubicin—uterine cancer	8.2e-05	0.00123	CcSEcCtD
Mifepristone—Vomiting—Etoposide—uterine cancer	8.19e-05	0.00123	CcSEcCtD
Mifepristone—Malnutrition—Doxorubicin—uterine cancer	8.18e-05	0.00123	CcSEcCtD
Mifepristone—Rash—Etoposide—uterine cancer	8.12e-05	0.00122	CcSEcCtD
Mifepristone—Dermatitis—Etoposide—uterine cancer	8.11e-05	0.00122	CcSEcCtD
Mifepristone—Headache—Etoposide—uterine cancer	8.06e-05	0.00121	CcSEcCtD
Mifepristone—Malaise—Epirubicin—uterine cancer	7.97e-05	0.0012	CcSEcCtD
Mifepristone—Back pain—Doxorubicin—uterine cancer	7.91e-05	0.00119	CcSEcCtD
Mifepristone—Muscle spasms—Doxorubicin—uterine cancer	7.87e-05	0.00118	CcSEcCtD
Mifepristone—Nausea—Etoposide—uterine cancer	7.65e-05	0.00115	CcSEcCtD
Mifepristone—Hypertension—Epirubicin—uterine cancer	7.63e-05	0.00115	CcSEcCtD
Mifepristone—Ill-defined disorder—Doxorubicin—uterine cancer	7.59e-05	0.00114	CcSEcCtD
Mifepristone—Myalgia—Epirubicin—uterine cancer	7.53e-05	0.00113	CcSEcCtD
Mifepristone—Arthralgia—Epirubicin—uterine cancer	7.53e-05	0.00113	CcSEcCtD
Mifepristone—Anxiety—Epirubicin—uterine cancer	7.5e-05	0.00113	CcSEcCtD
Mifepristone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	7.48e-05	0.00112	CcSEcCtD
Mifepristone—Discomfort—Epirubicin—uterine cancer	7.44e-05	0.00112	CcSEcCtD
Mifepristone—Malaise—Doxorubicin—uterine cancer	7.38e-05	0.00111	CcSEcCtD
Mifepristone—Dry mouth—Epirubicin—uterine cancer	7.36e-05	0.00111	CcSEcCtD
Mifepristone—Oedema—Epirubicin—uterine cancer	7.22e-05	0.00109	CcSEcCtD
Mifepristone—Infection—Epirubicin—uterine cancer	7.17e-05	0.00108	CcSEcCtD
Mifepristone—Nervous system disorder—Epirubicin—uterine cancer	7.08e-05	0.00106	CcSEcCtD
Mifepristone—Hypertension—Doxorubicin—uterine cancer	7.06e-05	0.00106	CcSEcCtD
Mifepristone—Skin disorder—Epirubicin—uterine cancer	7.01e-05	0.00105	CcSEcCtD
Mifepristone—Arthralgia—Doxorubicin—uterine cancer	6.97e-05	0.00105	CcSEcCtD
Mifepristone—Myalgia—Doxorubicin—uterine cancer	6.97e-05	0.00105	CcSEcCtD
Mifepristone—Anxiety—Doxorubicin—uterine cancer	6.94e-05	0.00104	CcSEcCtD
Mifepristone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	6.92e-05	0.00104	CcSEcCtD
Mifepristone—Discomfort—Doxorubicin—uterine cancer	6.88e-05	0.00104	CcSEcCtD
Mifepristone—Anorexia—Epirubicin—uterine cancer	6.88e-05	0.00104	CcSEcCtD
Mifepristone—Dry mouth—Doxorubicin—uterine cancer	6.81e-05	0.00103	CcSEcCtD
Mifepristone—Hypotension—Epirubicin—uterine cancer	6.74e-05	0.00101	CcSEcCtD
Mifepristone—Oedema—Doxorubicin—uterine cancer	6.68e-05	0.001	CcSEcCtD
Mifepristone—Infection—Doxorubicin—uterine cancer	6.63e-05	0.000998	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Epirubicin—uterine cancer	6.57e-05	0.000989	CcSEcCtD
Mifepristone—Nervous system disorder—Doxorubicin—uterine cancer	6.55e-05	0.000985	CcSEcCtD
Mifepristone—Insomnia—Epirubicin—uterine cancer	6.53e-05	0.000982	CcSEcCtD
Mifepristone—Skin disorder—Doxorubicin—uterine cancer	6.49e-05	0.000976	CcSEcCtD
Mifepristone—Dyspnoea—Epirubicin—uterine cancer	6.43e-05	0.000968	CcSEcCtD
Mifepristone—Somnolence—Epirubicin—uterine cancer	6.42e-05	0.000965	CcSEcCtD
Mifepristone—Anorexia—Doxorubicin—uterine cancer	6.36e-05	0.000958	CcSEcCtD
Mifepristone—Decreased appetite—Epirubicin—uterine cancer	6.27e-05	0.000944	CcSEcCtD
Mifepristone—Hypotension—Doxorubicin—uterine cancer	6.24e-05	0.000939	CcSEcCtD
Mifepristone—Gastrointestinal disorder—Epirubicin—uterine cancer	6.23e-05	0.000937	CcSEcCtD
Mifepristone—Fatigue—Epirubicin—uterine cancer	6.22e-05	0.000936	CcSEcCtD
Mifepristone—Pain—Epirubicin—uterine cancer	6.17e-05	0.000929	CcSEcCtD
Mifepristone—Constipation—Epirubicin—uterine cancer	6.17e-05	0.000929	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Doxorubicin—uterine cancer	6.08e-05	0.000915	CcSEcCtD
Mifepristone—Insomnia—Doxorubicin—uterine cancer	6.04e-05	0.000909	CcSEcCtD
Mifepristone—Dyspnoea—Doxorubicin—uterine cancer	5.95e-05	0.000896	CcSEcCtD
Mifepristone—Feeling abnormal—Epirubicin—uterine cancer	5.95e-05	0.000895	CcSEcCtD
Mifepristone—Somnolence—Doxorubicin—uterine cancer	5.94e-05	0.000893	CcSEcCtD
Mifepristone—Gastrointestinal pain—Epirubicin—uterine cancer	5.9e-05	0.000888	CcSEcCtD
Mifepristone—Decreased appetite—Doxorubicin—uterine cancer	5.8e-05	0.000873	CcSEcCtD
Mifepristone—Gastrointestinal disorder—Doxorubicin—uterine cancer	5.76e-05	0.000867	CcSEcCtD
Mifepristone—Fatigue—Doxorubicin—uterine cancer	5.76e-05	0.000866	CcSEcCtD
Mifepristone—Urticaria—Epirubicin—uterine cancer	5.73e-05	0.000863	CcSEcCtD
Mifepristone—Pain—Doxorubicin—uterine cancer	5.71e-05	0.000859	CcSEcCtD
Mifepristone—Constipation—Doxorubicin—uterine cancer	5.71e-05	0.000859	CcSEcCtD
Mifepristone—Abdominal pain—Epirubicin—uterine cancer	5.7e-05	0.000858	CcSEcCtD
Mifepristone—Body temperature increased—Epirubicin—uterine cancer	5.7e-05	0.000858	CcSEcCtD
Mifepristone—Feeling abnormal—Doxorubicin—uterine cancer	5.5e-05	0.000828	CcSEcCtD
Mifepristone—Gastrointestinal pain—Doxorubicin—uterine cancer	5.46e-05	0.000822	CcSEcCtD
Mifepristone—Hypersensitivity—Epirubicin—uterine cancer	5.32e-05	0.0008	CcSEcCtD
Mifepristone—Urticaria—Doxorubicin—uterine cancer	5.3e-05	0.000798	CcSEcCtD
Mifepristone—Abdominal pain—Doxorubicin—uterine cancer	5.28e-05	0.000794	CcSEcCtD
Mifepristone—Body temperature increased—Doxorubicin—uterine cancer	5.28e-05	0.000794	CcSEcCtD
Mifepristone—Asthenia—Epirubicin—uterine cancer	5.18e-05	0.000779	CcSEcCtD
Mifepristone—Pruritus—Epirubicin—uterine cancer	5.11e-05	0.000768	CcSEcCtD
Mifepristone—Diarrhoea—Epirubicin—uterine cancer	4.94e-05	0.000743	CcSEcCtD
Mifepristone—Hypersensitivity—Doxorubicin—uterine cancer	4.92e-05	0.00074	CcSEcCtD
Mifepristone—Asthenia—Doxorubicin—uterine cancer	4.79e-05	0.000721	CcSEcCtD
Mifepristone—Dizziness—Epirubicin—uterine cancer	4.77e-05	0.000718	CcSEcCtD
Mifepristone—Pruritus—Doxorubicin—uterine cancer	4.72e-05	0.000711	CcSEcCtD
Mifepristone—Vomiting—Epirubicin—uterine cancer	4.59e-05	0.00069	CcSEcCtD
Mifepristone—Diarrhoea—Doxorubicin—uterine cancer	4.57e-05	0.000687	CcSEcCtD
Mifepristone—Rash—Epirubicin—uterine cancer	4.55e-05	0.000685	CcSEcCtD
Mifepristone—Dermatitis—Epirubicin—uterine cancer	4.55e-05	0.000684	CcSEcCtD
Mifepristone—Headache—Epirubicin—uterine cancer	4.52e-05	0.00068	CcSEcCtD
Mifepristone—Dizziness—Doxorubicin—uterine cancer	4.42e-05	0.000664	CcSEcCtD
Mifepristone—Nausea—Epirubicin—uterine cancer	4.29e-05	0.000645	CcSEcCtD
Mifepristone—Vomiting—Doxorubicin—uterine cancer	4.25e-05	0.000639	CcSEcCtD
Mifepristone—Rash—Doxorubicin—uterine cancer	4.21e-05	0.000634	CcSEcCtD
Mifepristone—Dermatitis—Doxorubicin—uterine cancer	4.21e-05	0.000633	CcSEcCtD
Mifepristone—Headache—Doxorubicin—uterine cancer	4.18e-05	0.000629	CcSEcCtD
Mifepristone—Nausea—Doxorubicin—uterine cancer	3.97e-05	0.000597	CcSEcCtD
Mifepristone—AR—Integrated Breast Cancer Pathway—PTEN—uterine cancer	3.19e-05	0.00147	CbGpPWpGaD
Mifepristone—AR—SIDS Susceptibility Pathways—CTNNB1—uterine cancer	3.19e-05	0.00147	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—SRD5A2—uterine cancer	3.16e-05	0.00146	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—NDUFB11—uterine cancer	3.16e-05	0.00146	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—AKR1B10—uterine cancer	3.15e-05	0.00145	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	3.1e-05	0.00143	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	3.07e-05	0.00142	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—uterine cancer	3.06e-05	0.00141	CbGpPWpGaD
Mifepristone—NR3C1—AP-1 transcription factor network—TP53—uterine cancer	3.05e-05	0.00141	CbGpPWpGaD
Mifepristone—AR—Integrated Breast Cancer Pathway—EP300—uterine cancer	3.04e-05	0.0014	CbGpPWpGaD
Mifepristone—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—uterine cancer	3.03e-05	0.00139	CbGpPWpGaD
Mifepristone—NR3C1—Generic Transcription Pathway—PGR—uterine cancer	2.98e-05	0.00137	CbGpPWpGaD
Mifepristone—AR—SIDS Susceptibility Pathways—EP300—uterine cancer	2.96e-05	0.00137	CbGpPWpGaD
Mifepristone—ABCC1—Disease—AKR1B10—uterine cancer	2.94e-05	0.00135	CbGpPWpGaD
Mifepristone—PGR—Signaling by ERBB4—PIK3CA—uterine cancer	2.94e-05	0.00135	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	2.9e-05	0.00134	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—SUZ12—uterine cancer	2.88e-05	0.00133	CbGpPWpGaD
Mifepristone—AR—Integrated Breast Cancer Pathway—VEGFA—uterine cancer	2.88e-05	0.00133	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	2.87e-05	0.00132	CbGpPWpGaD
Mifepristone—CYP3A4—Metapathway biotransformation—AKR1C1—uterine cancer	2.84e-05	0.00131	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—uterine cancer	2.84e-05	0.00131	CbGpPWpGaD
Mifepristone—AR—Generic Transcription Pathway—CDKN2B—uterine cancer	2.81e-05	0.0013	CbGpPWpGaD
Mifepristone—AR—SIDS Susceptibility Pathways—VEGFA—uterine cancer	2.81e-05	0.00129	CbGpPWpGaD
Mifepristone—AR—Androgen receptor signaling pathway—AKT1—uterine cancer	2.81e-05	0.00129	CbGpPWpGaD
Mifepristone—NR3C1—Adipogenesis—CTNNB1—uterine cancer	2.8e-05	0.00129	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—NDUFB11—uterine cancer	2.76e-05	0.00127	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—SRD5A2—uterine cancer	2.76e-05	0.00127	CbGpPWpGaD
Mifepristone—PGR—Generic Transcription Pathway—ESR1—uterine cancer	2.75e-05	0.00127	CbGpPWpGaD
Mifepristone—PGR—Signaling by ERBB4—HRAS—uterine cancer	2.72e-05	0.00125	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	2.71e-05	0.00125	CbGpPWpGaD
Mifepristone—NR3C1—Glucocorticoid receptor regulatory network—TP53—uterine cancer	2.69e-05	0.00124	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	2.64e-05	0.00122	CbGpPWpGaD
Mifepristone—CYP2D6—Biological oxidations—CYP19A1—uterine cancer	2.64e-05	0.00122	CbGpPWpGaD
Mifepristone—NR3C1—Generic Transcription Pathway—ESR2—uterine cancer	2.62e-05	0.00121	CbGpPWpGaD
Mifepristone—NR3C1—SIDS Susceptibility Pathways—CXCL8—uterine cancer	2.62e-05	0.00121	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—RNF43—uterine cancer	2.61e-05	0.0012	CbGpPWpGaD
Mifepristone—CYP2D6—Metapathway biotransformation—CYP19A1—uterine cancer	2.6e-05	0.0012	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—STK11—uterine cancer	2.58e-05	0.00119	CbGpPWpGaD
Mifepristone—AR—Generic Transcription Pathway—SMAD3—uterine cancer	2.57e-05	0.00119	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	2.52e-05	0.00116	CbGpPWpGaD
Mifepristone—CYP3A4—Metapathway biotransformation—GPX3—uterine cancer	2.49e-05	0.00115	CbGpPWpGaD
Mifepristone—AR—Integrated Breast Cancer Pathway—KRAS—uterine cancer	2.45e-05	0.00113	CbGpPWpGaD
Mifepristone—ABCC1—Disease—RNF43—uterine cancer	2.43e-05	0.00112	CbGpPWpGaD
Mifepristone—ABCB1—Allograft Rejection—CXCL8—uterine cancer	2.43e-05	0.00112	CbGpPWpGaD
Mifepristone—NR3C1—SIDS Susceptibility Pathways—CTNNB1—uterine cancer	2.42e-05	0.00112	CbGpPWpGaD
Mifepristone—ABCB1—HIF-1-alpha transcription factor network—EP300—uterine cancer	2.4e-05	0.00111	CbGpPWpGaD
Mifepristone—PGR—Signaling by ERBB4—AKT1—uterine cancer	2.4e-05	0.00111	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—INHBA—uterine cancer	2.39e-05	0.0011	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	2.39e-05	0.0011	CbGpPWpGaD
Mifepristone—PGR—Gene Expression—EZH2—uterine cancer	2.36e-05	0.00109	CbGpPWpGaD
Mifepristone—CYP3A4—Biological oxidations—CYP11A1—uterine cancer	2.35e-05	0.00108	CbGpPWpGaD
Mifepristone—ABCB1—Transmembrane transport of small molecules—ABCC9—uterine cancer	2.32e-05	0.00107	CbGpPWpGaD
Mifepristone—CYP3A4—Metapathway biotransformation—CYP11A1—uterine cancer	2.31e-05	0.00107	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—uterine cancer	2.31e-05	0.00106	CbGpPWpGaD
Mifepristone—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—uterine cancer	2.29e-05	0.00106	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—STAR—uterine cancer	2.29e-05	0.00105	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—AKR1B1—uterine cancer	2.29e-05	0.00105	CbGpPWpGaD
Mifepristone—ABCB1—HIF-1-alpha transcription factor network—VEGFA—uterine cancer	2.28e-05	0.00105	CbGpPWpGaD
Mifepristone—NR3C1—Glucocorticoid receptor regulatory network—AKT1—uterine cancer	2.27e-05	0.00105	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	2.26e-05	0.00104	CbGpPWpGaD
Mifepristone—NR3C1—SIDS Susceptibility Pathways—EP300—uterine cancer	2.25e-05	0.00104	CbGpPWpGaD
Mifepristone—PGR—Gene Expression—ESR2—uterine cancer	2.19e-05	0.00101	CbGpPWpGaD
Mifepristone—CYP3A4—Metapathway biotransformation—AKR1C3—uterine cancer	2.19e-05	0.00101	CbGpPWpGaD
Mifepristone—AR—Integrated Breast Cancer Pathway—TP53—uterine cancer	2.18e-05	0.001	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—AKR1C1—uterine cancer	2.15e-05	0.000992	CbGpPWpGaD
Mifepristone—NR3C1—Generic Transcription Pathway—CDKN2B—uterine cancer	2.14e-05	0.000985	CbGpPWpGaD
Mifepristone—NR3C1—SIDS Susceptibility Pathways—VEGFA—uterine cancer	2.13e-05	0.000982	CbGpPWpGaD
Mifepristone—AR—Generic Transcription Pathway—ESR1—uterine cancer	2.1e-05	0.000967	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	2.03e-05	0.000936	CbGpPWpGaD
Mifepristone—ABCC1—Disease—AKR1C1—uterine cancer	2.01e-05	0.000925	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—AKR1B1—uterine cancer	2e-05	0.00092	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—STAR—uterine cancer	2e-05	0.00092	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—SRD5A2—uterine cancer	2e-05	0.00092	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—NDUFB11—uterine cancer	2e-05	0.00092	CbGpPWpGaD
Mifepristone—ABCB1—Allograft Rejection—VEGFA—uterine cancer	1.97e-05	0.000909	CbGpPWpGaD
Mifepristone—NR3C1—Generic Transcription Pathway—SMAD3—uterine cancer	1.95e-05	0.000899	CbGpPWpGaD
Mifepristone—AR—Gene Expression—PGR—uterine cancer	1.89e-05	0.000872	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	1.86e-05	0.00086	CbGpPWpGaD
Mifepristone—AR—Integrated Breast Cancer Pathway—AKT1—uterine cancer	1.84e-05	0.000847	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	1.8e-05	0.000832	CbGpPWpGaD
Mifepristone—AR—Gene Expression—EZH2—uterine cancer	1.8e-05	0.000828	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—POLD1—uterine cancer	1.8e-05	0.000828	CbGpPWpGaD
Mifepristone—PGR—Gene Expression—CDKN2B—uterine cancer	1.78e-05	0.00082	CbGpPWpGaD
Mifepristone—ABCC1—Disease—DCN—uterine cancer	1.73e-05	0.0008	CbGpPWpGaD
Mifepristone—CYP3A4—Biological oxidations—CYP19A1—uterine cancer	1.73e-05	0.000796	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—uterine cancer	1.72e-05	0.000793	CbGpPWpGaD
Mifepristone—CYP3A4—Metapathway biotransformation—CYP19A1—uterine cancer	1.7e-05	0.000785	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—AKR1C1—uterine cancer	1.68e-05	0.000774	CbGpPWpGaD
Mifepristone—AR—Gene Expression—ESR2—uterine cancer	1.66e-05	0.000768	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—AKR1C3—uterine cancer	1.66e-05	0.000764	CbGpPWpGaD
Mifepristone—PGR—Gene Expression—SMAD3—uterine cancer	1.62e-05	0.000749	CbGpPWpGaD
Mifepristone—NR3C1—Generic Transcription Pathway—ESR1—uterine cancer	1.59e-05	0.000734	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—POLD1—uterine cancer	1.57e-05	0.000722	CbGpPWpGaD
Mifepristone—ABCC1—Disease—AKR1C3—uterine cancer	1.54e-05	0.000712	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—YWHAE—uterine cancer	1.54e-05	0.00071	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	1.52e-05	0.000702	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—SRD5A2—uterine cancer	1.51e-05	0.000694	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—NDUFB11—uterine cancer	1.51e-05	0.000694	CbGpPWpGaD
Mifepristone—ABCC1—Disease—HMGA1—uterine cancer	1.5e-05	0.000694	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—RRM2—uterine cancer	1.5e-05	0.00069	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—FBXW7—uterine cancer	1.48e-05	0.000681	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—AKR1C1—uterine cancer	1.46e-05	0.000675	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—DCN—uterine cancer	1.45e-05	0.00067	CbGpPWpGaD
Mifepristone—ABCB1—HIF-1-alpha transcription factor network—AKT1—uterine cancer	1.45e-05	0.00067	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—STAR—uterine cancer	1.44e-05	0.000665	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—AKR1B1—uterine cancer	1.44e-05	0.000665	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—PGR—uterine cancer	1.43e-05	0.000662	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—NDUFB11—uterine cancer	1.42e-05	0.000654	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—SRD5A2—uterine cancer	1.42e-05	0.000654	CbGpPWpGaD
Mifepristone—ABCC1—Disease—FBXW7—uterine cancer	1.38e-05	0.000634	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—CYP11A1—uterine cancer	1.37e-05	0.000631	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—EZH2—uterine cancer	1.36e-05	0.000628	CbGpPWpGaD
Mifepristone—AR—Gene Expression—CDKN2B—uterine cancer	1.36e-05	0.000625	CbGpPWpGaD
Mifepristone—PGR—Gene Expression—ESR1—uterine cancer	1.33e-05	0.000611	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—RRM2—uterine cancer	1.31e-05	0.000602	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—AKR1C3—uterine cancer	1.29e-05	0.000596	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—STK11—uterine cancer	1.29e-05	0.000595	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—DCN—uterine cancer	1.27e-05	0.000584	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—ESR2—uterine cancer	1.26e-05	0.000582	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	1.26e-05	0.000582	CbGpPWpGaD
Mifepristone—AR—Gene Expression—SMAD3—uterine cancer	1.24e-05	0.000571	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—SOCS3—uterine cancer	1.21e-05	0.000557	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—CYP11A1—uterine cancer	1.19e-05	0.000551	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	1.17e-05	0.000539	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—CDKN2B—uterine cancer	1.16e-05	0.000533	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—POLD1—uterine cancer	1.13e-05	0.000522	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—AKR1C3—uterine cancer	1.13e-05	0.00052	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—IGF1R—uterine cancer	1.12e-05	0.000518	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	1.11e-05	0.00051	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—AKR1B1—uterine cancer	1.09e-05	0.000502	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—STAR—uterine cancer	1.09e-05	0.000502	CbGpPWpGaD
Mifepristone—ABCC1—Disease—CDKN2B—uterine cancer	1.08e-05	0.000497	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	1.08e-05	0.000497	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—AKR1C1—uterine cancer	1.06e-05	0.000488	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—SMAD3—uterine cancer	1.06e-05	0.000487	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—CDKN2B—uterine cancer	1.03e-05	0.000474	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	1.03e-05	0.000474	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—AKR1B1—uterine cancer	1.03e-05	0.000473	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—STAR—uterine cancer	1.03e-05	0.000473	CbGpPWpGaD
Mifepristone—AR—Gene Expression—ESR1—uterine cancer	1.01e-05	0.000466	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—FGFR2—uterine cancer	1.01e-05	0.000464	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—STK11—uterine cancer	1.01e-05	0.000464	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—CYP19A1—uterine cancer	1.01e-05	0.000464	CbGpPWpGaD
Mifepristone—ABCC1—Disease—SMAD3—uterine cancer	9.84e-06	0.000454	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	9.73e-06	0.000449	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	9.45e-06	0.000436	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—RRM2—uterine cancer	9.44e-06	0.000435	CbGpPWpGaD
Mifepristone—ABCC1—Disease—FGFR2—uterine cancer	9.39e-06	0.000433	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—SMAD3—uterine cancer	9.39e-06	0.000433	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—NDUFB11—uterine cancer	9.28e-06	0.000428	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—SRD5A2—uterine cancer	9.28e-06	0.000428	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—DCN—uterine cancer	9.16e-06	0.000422	CbGpPWpGaD
Mifepristone—ABCC1—Disease—MTHFR—uterine cancer	9.04e-06	0.000417	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	9.02e-06	0.000416	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—STK11—uterine cancer	8.78e-06	0.000405	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—CYP19A1—uterine cancer	8.78e-06	0.000405	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—CYP11A1—uterine cancer	8.63e-06	0.000398	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—ESR1—uterine cancer	8.62e-06	0.000397	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—POLD1—uterine cancer	8.54e-06	0.000394	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	8.27e-06	0.000381	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—AKR1C3—uterine cancer	8.15e-06	0.000376	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—POLD1—uterine cancer	8.05e-06	0.000371	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—AKR1C1—uterine cancer	7.99e-06	0.000368	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—ESR1—uterine cancer	7.66e-06	0.000353	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	7.6e-06	0.00035	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—CCL2—uterine cancer	7.59e-06	0.00035	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—MTHFR—uterine cancer	7.57e-06	0.000349	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—AKR1C1—uterine cancer	7.53e-06	0.000347	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	7.35e-06	0.000339	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—RRM2—uterine cancer	7.12e-06	0.000328	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—DCN—uterine cancer	6.91e-06	0.000319	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—RRM2—uterine cancer	6.71e-06	0.000309	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—AKR1B1—uterine cancer	6.71e-06	0.000309	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—STAR—uterine cancer	6.71e-06	0.000309	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	6.67e-06	0.000308	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—MTHFR—uterine cancer	6.6e-06	0.000304	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—DCN—uterine cancer	6.51e-06	0.0003	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—CYP11A1—uterine cancer	6.51e-06	0.0003	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—STK11—uterine cancer	6.35e-06	0.000293	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—CYP19A1—uterine cancer	6.35e-06	0.000293	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—ERBB2—uterine cancer	6.32e-06	0.000292	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	6.21e-06	0.000286	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—AKR1C3—uterine cancer	6.15e-06	0.000284	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—CYP11A1—uterine cancer	6.14e-06	0.000283	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—CXCL8—uterine cancer	6e-06	0.000277	CbGpPWpGaD
Mifepristone—ABCC1—Disease—ERBB2—uterine cancer	5.9e-06	0.000272	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—CDKN1B—uterine cancer	5.86e-06	0.00027	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—AKR1C3—uterine cancer	5.8e-06	0.000267	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—CTNNB1—uterine cancer	5.53e-06	0.000255	CbGpPWpGaD
Mifepristone—ABCC1—Disease—CDKN1B—uterine cancer	5.46e-06	0.000252	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—PTEN—uterine cancer	5.39e-06	0.000249	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—POLD1—uterine cancer	5.26e-06	0.000243	CbGpPWpGaD
Mifepristone—ABCC1—Disease—CTNNB1—uterine cancer	5.16e-06	0.000238	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—EP300—uterine cancer	5.14e-06	0.000237	CbGpPWpGaD
Mifepristone—ABCC1—Disease—PTEN—uterine cancer	5.03e-06	0.000232	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—AKR1C1—uterine cancer	4.92e-06	0.000227	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—VEGFA—uterine cancer	4.87e-06	0.000225	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—NRAS—uterine cancer	4.81e-06	0.000222	CbGpPWpGaD
Mifepristone—ABCC1—Disease—EP300—uterine cancer	4.79e-06	0.000221	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—STK11—uterine cancer	4.79e-06	0.000221	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—CYP19A1—uterine cancer	4.79e-06	0.000221	CbGpPWpGaD
Mifepristone—PGR—Gene Expression—AKT1—uterine cancer	4.78e-06	0.00022	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—MTHFR—uterine cancer	4.77e-06	0.00022	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—STK11—uterine cancer	4.52e-06	0.000208	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—CYP19A1—uterine cancer	4.52e-06	0.000208	CbGpPWpGaD
Mifepristone—ABCC1—Disease—NRAS—uterine cancer	4.49e-06	0.000207	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—RRM2—uterine cancer	4.39e-06	0.000202	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—DCN—uterine cancer	4.26e-06	0.000196	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—PTEN—uterine cancer	4.21e-06	0.000194	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—KRAS—uterine cancer	4.14e-06	0.000191	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—EP300—uterine cancer	4.02e-06	0.000185	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—CYP11A1—uterine cancer	4.01e-06	0.000185	CbGpPWpGaD
Mifepristone—ABCC1—Disease—KRAS—uterine cancer	3.86e-06	0.000178	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—PIK3CA—uterine cancer	3.8e-06	0.000175	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—AKR1C3—uterine cancer	3.79e-06	0.000175	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—TP53—uterine cancer	3.68e-06	0.00017	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—PTEN—uterine cancer	3.67e-06	0.000169	CbGpPWpGaD
Mifepristone—AR—Gene Expression—AKT1—uterine cancer	3.64e-06	0.000168	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—MTHFR—uterine cancer	3.6e-06	0.000166	CbGpPWpGaD
Mifepristone—ABCC1—Disease—PIK3CA—uterine cancer	3.55e-06	0.000164	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—HRAS—uterine cancer	3.52e-06	0.000162	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—EP300—uterine cancer	3.5e-06	0.000161	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—MTHFR—uterine cancer	3.39e-06	0.000156	CbGpPWpGaD
Mifepristone—ABCC1—Disease—HRAS—uterine cancer	3.28e-06	0.000151	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—AKT1—uterine cancer	3.11e-06	0.000143	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—PIK3CA—uterine cancer	2.97e-06	0.000137	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—CYP19A1—uterine cancer	2.95e-06	0.000136	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—STK11—uterine cancer	2.95e-06	0.000136	CbGpPWpGaD
Mifepristone—ABCC1—Disease—AKT1—uterine cancer	2.9e-06	0.000134	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—AKT1—uterine cancer	2.76e-06	0.000127	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—PTEN—uterine cancer	2.65e-06	0.000122	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—PIK3CA—uterine cancer	2.59e-06	0.000119	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—EP300—uterine cancer	2.53e-06	0.000117	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—AKT1—uterine cancer	2.43e-06	0.000112	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—MTHFR—uterine cancer	2.22e-06	0.000102	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—AKT1—uterine cancer	2.12e-06	9.76e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—PTEN—uterine cancer	2e-06	9.24e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—EP300—uterine cancer	1.91e-06	8.81e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—PTEN—uterine cancer	1.89e-06	8.7e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—PIK3CA—uterine cancer	1.87e-06	8.63e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—EP300—uterine cancer	1.8e-06	8.3e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—AKT1—uterine cancer	1.53e-06	7.05e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—PIK3CA—uterine cancer	1.41e-06	6.52e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—PIK3CA—uterine cancer	1.33e-06	6.14e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—PTEN—uterine cancer	1.23e-06	5.69e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—EP300—uterine cancer	1.18e-06	5.43e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—AKT1—uterine cancer	1.15e-06	5.32e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—AKT1—uterine cancer	1.09e-06	5.02e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—PIK3CA—uterine cancer	8.71e-07	4.01e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—AKT1—uterine cancer	7.11e-07	3.28e-05	CbGpPWpGaD
